Patents by Inventor Erol Bayburt

Erol Bayburt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prodrugs of compounds that inhibit TRPV1 receptor
    Publication number: 20070099954
    Abstract: Compounds of formula (I) wherein A, R1, R2, and R3 are defined in the specification, and which are useful as therapeutic compounds particularly for treating disorders or conditions associated with inflammation, pain, bladder overactivity, urinary incontinence, and other disorders caused by or exacerbated by TRPV1.
    Type: Application
    Filed: October 27, 2006
    Publication date: May 3, 2007
    Inventors: Arthur Gomtsyan, Erol Bayburt, John Koenig, Kennan Marsh, Robert Schmidt, Chih-Hung Lee, Weili Wang, Jerome Daanen, Brian Brown
  • Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
    Publication number: 20060128689
    Abstract: Compounds that are antagonists of the VR1 receptor, having formula (I) or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A1, A2, A3, A4, R7, R8, R9, X, Y, Z, L, n, and m, are as defined herein, and are useful in disorders prevented or ameliorated by inhibiting the VR1 receptor.
    Type: Application
    Filed: November 22, 2005
    Publication date: June 15, 2006
    Inventors: Arthur Gomtsyan, Erol Bayburt, Robert Schmidt, Chih-Hung Lee, Brian Brown, Tammie Jinkerson, John Koenig, Jerome Daanen, Steven Latshaw
  • Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
    Publication number: 20060035934
    Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.
    Type: Application
    Filed: October 26, 2005
    Publication date: February 16, 2006
    Inventors: Arthur Gomtsyan, Erol Bayburt, John Koenig, Chih-Hung Lee
  • Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
    Publication number: 20050113576
    Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
    Type: Application
    Filed: August 4, 2004
    Publication date: May 26, 2005
    Inventors: Chih-Hung Lee, Erol Bayburt, Stanley DiDomenico, Irene Drizin, Arthur Gomtsyan, John Koenig, Richard Perner, Robert Schmidt, Sean Turner, Tammie Jinkerson, Guo Zheng
  • Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
    Publication number: 20050043351
    Abstract: The present invention discloses novel compounds of general formula (I) or a pharmaceutically acceptable salt or prodrug thereof (in which X1—X5, R5—R8b, Z1-Z2 and Ar1 are defined herein), a method for inhibiting the VR1 receptor in mammals using these compounds, a method for controlling pain in mammals, and pharmaceutical compositions including those compounds and a process for making those compounds.
    Type: Application
    Filed: June 9, 2004
    Publication date: February 24, 2005
    Inventors: Arthur Gomtsyan, Erol Bayburt, Chih-Hung Lee, John Koenig, Robert Schmidt, Kirill Lukin, Margaret Hsu, Marvin Leanna, Russell Cink, Gilles Chambournier
  • FLUORENES AND ANTHRACENES THAT INHIBIT P2X3 AND P2X2/3 CONTAINING RECEPTORS
    Publication number: 20040019042
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: July 26, 2002
    Publication date: January 29, 2004
    Inventors: Chih-Hung Lee, Meiqun Jiang, Richard Perner, Arthur Gomtsyan, Erol Bayburt, Guo Zhu Zheng